InvestorsHub Logo
Followers 69
Posts 6506
Boards Moderated 0
Alias Born 02/10/2010

Re: JNdouble1 post# 295019

Saturday, 07/30/2022 12:29:48 PM

Saturday, July 30, 2022 12:29:48 PM

Post# of 330443
1) My response was to your post re Sofpulse, list of 7 Trials with no NIH results

<<<<<< Not sure why there is some much attention being paid here to the SofPulse product >>>>>

2) Trying to lump BIEL, OEM contracts with KT Tape/Scott-DJO/SAI Brands, in with ENDV, who had $73k in Sales for 2021, is ridiculous.

<<<<<< two different products, both FDA authorized, both clinically proven, are unable to find a market >>>>>>

3) Setting arbitrary deadlines for the success/failure of BIEL have not worked out well for the last 15 years.

<<<<<<<<< next 2 quarters are do or die for BIEL >>>>>>>>>>>

4) Quotes posted with no link to the actual Study/Trial, why not provide a link to the Study/Trial so that readers can see the source material?

<<<<<< "See Attached Study" >>>>>>


5) Serious Red Flag , Claims of 300% and 400% reduction in Pain. Pain is generally quantified with numers, a 1-10 scale being most common. If a patient's Pain is reduced from 10 to 5 that is a 50% reduction, from 10 to 1 would be a 90% decrease. There is no 400% decrease on a numerical pain scale.